Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-14

Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of CKD-348 in hypertension and dyslipidemias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CKD-348 (CKD-348)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension, Dyslipidemias | Phase 3 | Status: UNKNOWN